MXPA01007952A - Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas. - Google Patents
Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.Info
- Publication number
- MXPA01007952A MXPA01007952A MXPA01007952A MXPA01007952A MXPA01007952A MX PA01007952 A MXPA01007952 A MX PA01007952A MX PA01007952 A MXPA01007952 A MX PA01007952A MX PA01007952 A MXPA01007952 A MX PA01007952A MX PA01007952 A MXPA01007952 A MX PA01007952A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- same
- treating diseases
- based formulations
- arginine based
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Abstract
Una mezcla terapeutica que consiste de L-Arginina y un agonista de NOS (por ejemplo, Doxazofin) esta descrita para el tratamiento de enfermedades.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11890399P | 1999-02-05 | 1999-02-05 | |
PCT/US2000/002798 WO2000045809A1 (en) | 1999-02-05 | 2000-02-04 | L-arginine based formulations for treating diseases and methods of using same |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01007952A true MXPA01007952A (es) | 2004-03-26 |
Family
ID=22381443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA01007952A MXPA01007952A (es) | 1999-02-05 | 2000-02-04 | Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1150669A4 (es) |
JP (1) | JP2002536325A (es) |
AU (1) | AU3356000A (es) |
CA (1) | CA2361575A1 (es) |
MX (1) | MXPA01007952A (es) |
WO (1) | WO2000045809A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5968983A (en) | 1994-10-05 | 1999-10-19 | Nitrosystems, Inc | Method and formulation for treating vascular disease |
US6425881B1 (en) * | 1994-10-05 | 2002-07-30 | Nitrosystems, Inc. | Therapeutic mixture useful in inhibiting lesion formation after vascular injury |
WO2000056328A1 (en) | 1999-03-19 | 2000-09-28 | Enos Pharmaceuticals, Inc. | Increasing cerebral bioavailability of drugs |
JP5065570B2 (ja) * | 2002-09-06 | 2012-11-07 | 第一三共ヘルスケア株式会社 | 血管内皮性酸化窒素の合成促進剤 |
CA2536961A1 (en) * | 2003-08-14 | 2005-02-24 | Blue Medical Devices B.V. | Endoluminal prosthesis comprising a therapeutic agent |
EP1591118A1 (en) * | 2004-04-27 | 2005-11-02 | Nutri-Fit GmbH & Co. KG | Use of melatonin in preventing postoperative complications |
JP2012041296A (ja) * | 2010-08-19 | 2012-03-01 | Medience Corp | 血管内皮機能改善剤、一酸化窒素産生促進剤、及び飲食品 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4758569A (en) * | 1987-08-26 | 1988-07-19 | Pfizer Inc. | Doxazosin as an anti-atherosclerosis agent |
US5270323A (en) * | 1990-05-31 | 1993-12-14 | Pfizer Inc. | Method of treating impotence |
WO1994009786A1 (en) * | 1992-11-04 | 1994-05-11 | Sepracor, Inc. | Methods and compositions of (+) doxazosin for the treatment of hypertension |
JPH08511530A (ja) * | 1993-06-11 | 1996-12-03 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 内因性酸化窒素生成又は活性の調節による血管変性疾患の治療 |
US5543430A (en) * | 1994-10-05 | 1996-08-06 | Kaesemeyer; W. H. | Method and formulation of stimulating nitric oxide synthesis |
EP0745332B1 (en) * | 1995-06-01 | 2004-09-29 | N.V. Nutricia | Clinical nutritional composition |
FR2774593B1 (fr) * | 1998-02-12 | 2000-05-05 | Philippe Gorny | Obtention d'un medicament destine a combattre les dysfonctions sexuelles feminines |
US6277884B1 (en) * | 1998-06-01 | 2001-08-21 | Nitromed, Inc. | Treatment of sexual dysfunction with N-hydroxyguanidine compounds |
-
2000
- 2000-02-04 MX MXPA01007952A patent/MXPA01007952A/es unknown
- 2000-02-04 AU AU33560/00A patent/AU3356000A/en not_active Abandoned
- 2000-02-04 WO PCT/US2000/002798 patent/WO2000045809A1/en not_active Application Discontinuation
- 2000-02-04 CA CA002361575A patent/CA2361575A1/en not_active Abandoned
- 2000-02-04 EP EP00911701A patent/EP1150669A4/en not_active Withdrawn
- 2000-02-04 JP JP2000596929A patent/JP2002536325A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2361575A1 (en) | 2000-08-10 |
EP1150669A4 (en) | 2005-06-22 |
AU3356000A (en) | 2000-08-25 |
JP2002536325A (ja) | 2002-10-29 |
EP1150669A1 (en) | 2001-11-07 |
WO2000045809A1 (en) | 2000-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE376832T1 (de) | Verzögert freisetzende formulierungen von oxymorphon | |
AU7031500A (en) | Therapeutic quinazoline compounds | |
DE69722426D1 (de) | Isobutylgaba und dessen derivate zur schmerzbehandlung | |
PL374865A1 (en) | Treatment of tnf alpha related disorders | |
WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
AU2207000A (en) | Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia | |
AU5624699A (en) | Use of 5ht-6 antagonists | |
BG105534A (en) | 5ht1 means and method for the treatment of migraine | |
DK0998287T3 (da) | Anvendelse af levobupivacain | |
CA2339384A1 (en) | Improved method for targeted topical treatment of disease | |
MXPA01008993A (es) | Tratamiento de combinacion para depresion y ansiedad. | |
AU2001249684A1 (en) | Nasal administration of agents for the treatment of gastroparesis | |
HK1029944A1 (en) | Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway | |
MXPA01007952A (es) | Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas. | |
AU2002332488A8 (en) | R-bambuterol, its preparation and therapeutic uses | |
GB9907571D0 (en) | Compounds | |
NO20005757D0 (no) | Cabergolin og pramipexol - nye anvendelser og kombinasjoner | |
MXPA02001204A (es) | Compuestos calciliticos. | |
MY124071A (en) | Treatment of viral disease in swine | |
EP1671630A3 (en) | L-Arginine based formulations for treating diseases and methods of using the same | |
EP0904094A4 (en) | TREATMENT OF BONE DISEASES USING ADRENOMEDULLINE | |
ES2159479A1 (es) | Nuevos indazoles como inhibidores de la ciclooxigenasa-ii | |
AU5870298A (en) | 1,4-dihydropyridin derivatives and their use in therapy |